Clinical Trial Update: Apremilast and Moderate to Severe Chronic Hand Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating apremilast for moderate to severe chronic hand dermatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: George Washington University | Conditions: Chronic Hand Dermatitis | Phase 4 | Status: WITHDRAWN